|
HS Code |
165399 |
| Product Name | Calcium Borogluconate Injection Veterinary Grade API |
| Chemical Formula | C12H22CaO14·B(OH)3 |
| Appearance | Clear, colorless to slightly yellowish solution |
| Intended Use | Veterinary calcium supplement |
| Form | Injection (also suitable for Tablets, Capsules, Powders, Granules, Premix, Solutions) |
| Main Ingredient | Calcium Borogluconate |
| Calcium Content | Typically 23% calcium (as calcium borogluconate) |
| Solubility | Water soluble |
| Ph Range | 6.0 - 7.5 |
| Storage Conditions | Store below 25°C, protect from light |
As an accredited Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sterile glass vial containing 100ml clear solution, sealed with a rubber stopper and aluminum cap, labeled "Calcium Borogluconate Injection 100ml." |
| Shipping | Shipping for Calcium Borogluconate Injection Veterinary Grade API is conducted in secure, tamper-proof packaging to maintain product integrity. The chemical is dispatched in compliant containers suitable for tablets, injections, capsules, powders, granules, premix, or solutions, with clear labeling and documentation, ensuring safe, prompt delivery under regulated temperature and handling conditions. |
| Storage | Store **Calcium Borogluconate Injection Veterinary Grade API** in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible materials. Keep the container tightly closed and protected from moisture. Maintain storage temperatures below 25°C. Ensure the storage area is secure and accessible only to authorized personnel. Follow all relevant safety and regulatory guidelines for veterinary pharmaceuticals. |
|
Purity 98%: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a purity of 98% is used in oral supplement formulations for livestock, where it enhances calcium absorption and bioavailability. Particle Size 50 microns: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a particle size of 50 microns is used in poultry feed premix production, where it ensures uniform dispersion and improved product consistency. Solubility in Water ≥ 98%: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with solubility in water ≥ 98% is used in injectable veterinary solutions, where rapid dissolution facilitates quick administration and absorption. pH Range 6.5-7.5: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a pH range of 6.5-7.5 is used in liquid oral dosage forms, where it maintains product stability and safety for animal use. Stability Temperature up to 40°C: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability temperature up to 40°C is used in veterinary premixes for tropical climates, where it prevents degradation during storage and transportation. Molecular Weight 430.18 g/mol: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with molecular weight 430.18 g/mol is used in precision granule formulations, where it guarantees accurate dosing and reproducibility. Boron Content 1.5%: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with boron content 1.5% is used in fortified animal health solutions, where it supports bone metabolism and reduces deficiency symptoms. Melting Point 120°C: Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a melting point of 120°C is used in the production of heat-processed tablets, where thermal resistance ensures ingredient integrity. |
Competitive Calcium Borogluconate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In animal health, practicality is often the deciding factor in dairy farms, feedlots, and veterinary clinics. We have been hands-on, producing Calcium Borogluconate Injection Veterinary Grade API for years, so we see the difference a reliable active ingredient makes—especially under pressure when hypocalcemia or milk fever strikes. Our product sits at the core of treatments, but it is the ground-level results that count. Animals need more than textbook calcium levels; they need a form that works fast, is gentle on tissue, and doesn’t complicate the work for those giving care.
We manufacture Calcium Borogluconate API for use in tablets, oral powders, capsules, injectable preparations, premixes, water-dispersible solutions, and direct-dosing granules. Our standard model contains a carefully balanced combination of calcium gluconate and borogluconate, produced under current GMP and well within major pharmacopoeia requirements. Each batch undergoes direct calcium content testing, borate analysis, and impurity checks—not only for paperwork but for what matters in daily veterinary practice: consistent absorption, predictable solubility, and compatibility with various excipients and vehicles.
Tablets or capsules for preventative applications rely on our API because the flow properties and pressed density have been tailored to minimize sticking and capping during production. For injectable forms, users repeatedly comment on low endotoxin results and rapid dissolution, with no insoluble flakes to clog filters or syringes. We judge quality in both the finished solution and its stability profile: no precipitation, no visible color changes, and a buffered pH to keep tissues safe, based on feedback from veterinarians and pharmacists actually using the product.
Simple calcium salts can pass purity checks but fall short in real use. Without proper borogluconate ratios or impurity management, some sources lead to irritation on injection or fail to bring animals out of acute calcium crisis. Our Calcium Borogluconate API features a dual-action profile: the gluconate component delivers a controlled, bioavailable calcium release, while boron compounds support stable serum levels post-administration. This balance comes from ongoing trialing on live herds and routine feedback cycles with practicing vets, not only from reference books.
Many generic calcium products claim solubility, but batch-to-batch inconsistency often causes unanticipated precipitation or delayed response in the field. Our process ensures solubility metrics are not just theoretical—they’re confirmed in both cold- and room-temperature saline, so field use is reliable. This attention to detail means our partners do not waste time with reconstitution or deal with needle blockages. Over the years, clients have told us fewer animals reject the product due to lower local irritation, and post-treatment recovery moves closer to textbook expectations, even in high-producing dairy herds.
Differences show most clearly in injectable solutions. We target near-neutral pH and minimize pyrogens at each filtration stage. Clients report that the API mixes readily with both standard diluents and custom excipient blends, supporting in-house formulation or large-scale contract manufacturing. Hard-earned production knowhow allows fast turnaround on custom grades—for example, adjusting calcium or boron levels, or optimizing mesh size for specialized granule or premix lines—something less-focused suppliers rarely support.
Every production batch sees review not only from our QA team, but practical hands—colleagues who have observed injectables separating or failing in heat, animals refusing oral powders, and the tangible difference between rapid clinical recovery and drawn-out hypocalcemia. As manufacturers, we control and witness the exact temps and reaction times that determine solubility and precipitate risk. We keep lines running 24/7 at times of calving surge, so end users always have the supply they need. There’s no outsourcing or repacking in the process, which keeps variability low.
Where other products may include anticaking agents or extended preservatives to patch up core flaws, we build in stability with controlled crystallization and “just enough” water of hydration—learned by tracking shelf-life degradation over years, not just a single stability trial. Clients running powder filling lines or tablet presses get product that behaves the same with every shipment, helping prevent costly batch rejections.
Field observations taught us that a stable calcium borogluconate API reduces emergency callouts and animal fatalities. In hot climates, rapid precipitation threatens injectable solutions. During cold storage, some additives clump, and powders pick up moisture—rendering them sticky or un-dosable. Our formulation is monitored for both accelerated and real-world ambient conditions, matching the realities of global farm and veterinary logistics. Because batch consistency reduces the temptation for over- or under-dosing, animal health improves and operation risks fall. These are lessons only years of repetition and careful end user dialogue make clear.
We commit to avoiding cheap shortcuts—keeping heavy metals lower than pharmacopeial limits, screening for minor bioactives that can interfere with standard health outcomes, and excluding suspect additives even before new regulations arrive. Decision-makers—veterinarians, technical buyers, and formulation scientists—come to us when animal health outcomes depend on time-tested, no-nonsense calcium delivery. In our operation, plant-level transparency wins trust more than glossy paperwork.
Scaling up often means trouble elsewhere. Mass-produced calcium sources risk variations in crystal size and moisture content, creating downstream problems—clumping, separation in injectables, or inconsistent active content in tablets. We’ve invested in real-time laser particle counters, automated moisture meters, and direct feeding of analytics to production adjustment. As a result, hospitals treating milk fever or hypocalcemia emergencies using solutions made from our API rarely see the “surprise” failures—like bottle sedimentation or unpredictable calcium spike—which mean the difference between a vet’s night callout ending in recovery or loss.
Our plant-level quality control programs trace each lot from raw borax and gluconic acid input through finished API packaging, logging all deviations and real-world recovery rates. Sometimes that means holding a batch back for rehydration or secondary drying, or fine-tuning synthesis temperatures to hit that sweet spot between physical stability and quick solubility. We treat customer complaints and end user feedback as production data, not just paperwork to check a box. Each year, changes in veterinary practice or new formulation tech emerge, and we adjust processes that have real-world impact within months, not years.
As regulations evolve, demand from global markets stretches from basic injectable forms to advanced premix, powder, and tablet applications in multiple animal species. Our Calcium Borogluconate API performs across this spectrum by focusing on three core elements: rapid solubility under farm and clinic conditions, a balance of calcium and boron for reliable recovery, and proven compatibility with vitamins and trace mineral blends.
In tablet or capsule manufacturing, compressibility and minimal dusting matter. Powders for feed premix need to stay free-flowing during bulk transport. Injectable solutions require absolute confidence in clarity and tissue safety. Our own teams work side by side with these requirements, so batches produced for oral, injectable, or water-dispersible use meet the specific handling and animal health demands every time. These solutions emerge from ongoing relationships with end users and adaptation to their real-world remedies, never off-the-shelf recipes.
Dairy veterinarians, feedlot managers, and pharmaceutical processors provide direct feedback: recovery rates go up when calcium spikes are reliable, side reactions are low, and mixing takes seconds instead of minutes. Some of the best insights come from field trials on crowded cattle trucks, pasture calving sites, or remote clinics struggling with unreliable electricity. We’ve had clients test reconstitution in dusty barns, with water from steel tanks, not lab-grade glassware. Because field conditions often differ starkly from textbook setups, we model our quality goals on those environments, not just the lab benchmark.
Veterinary professionals treating several dozen hypocalcemic animals during a calving surge don’t have the luxury of patience for slow-dissolving or irritating salts. Oral or injectable, rapid uptake with minimum secondary stress shortens downtime and reduces overall herd health costs. Feed manufacturers running continuous premix operations avoid costly line shutdowns due to caking or slow blending. Farm staff administering drenches or tablets during routine health drives benefit from uniform dispersion and easy dosing, which cuts down on mistakes and improves animal welfare.
Time-tested calcium borogluconate isn’t about meeting a shelf life printed on a certificate—it’s about grains that stay free-flowing through harvest humidity, and solutions that stay clear months after mixing. We monitor stability in real-world transport—sweating truck trailers, uncooled clinics, and variable barn storage—by pulling samples at fixed intervals. This approach provides practical risk management, not just regulatory compliance.
Our packaging follows what real distribution chains demand: moisture barriers measured in months, not days; UV resistance so no color shift occurs in south-facing storerooms; and packaging that suits automated and manual dosing set-ups alike, based on actual distributor workarounds we’ve seen in play. All stability tests extend well past initial test points—12, 18, even 36 months for certain lots—so end users do not face unwelcome surprises halfway through a season.
Good calcium borogluconate starts clean. We keep trace elements below the strictest pharmacopoeia worry points: arsenic, lead, cadmium, and mercury are measured at every batch, and records are kept available for scrutiny by any food safety authority or quality auditor. Veterinary safety depends on endotoxin control in injectable forms—our filtration and precipitation controls target thresholds seen in the top human-grade API plants. Because local tissue reactions or allergic responses can turn a simple injection into a critical event, we limit side additives, avoid animal-derived stabilizers, and never bulk with unnecessary sugars.
We run batch “worst-case” tests with typical dilution fluids: everything from ringers and saline to locally sourced water, catching unknown reactivity before an end user ever does. This means both caregivers and animals avoid unexpected tissue responses or difficult administration, and preparers waste less time fixing issues in the field.
Every calcium API’s environmental impact rests with its production process. Our synthesis routes minimize borate discharge into wastewater streams, reuse process water, and keep off-gassing in check by in-house monitoring. Our packaging options are selected for recyclability and minimized shelf impact. Feedback from regional regulators and our own transport leads prompts us to redesign drums, bags, and bottles to match disposal programs and minimize landfill risk. These moves do not just stay on paper—they have practical impact on cost, waste volume, and user reputation downstream, especially as local and global compliance standards tighten.
Over decades, the practical concerns have built our process—animal welfare, time savings for veterinarians, simpler logistics for clinics, and easy adoption for manufacturers. Cases where veterinarians reduce emergency visits per season or feedlots see faster post-milk fever recovery come straight from adjusting crystal size or purity, based not in theory but in post-market review. Every formulation change, packaging fix, or impurity control stems from real impact, both for animals and for those administering care.
By staying directly connected to routine users—not only technical staff—and constantly monitoring new veterinary studies, we adapt our calcium borogluconate for the conditions and real variables that matter on today’s farm, feedlot, or clinic. Our product has shown resilience through changing diagnostic practices, tighter residue control, and broader species application, meeting the needs of dairy cows, beef herds, sheep, goats, and—by special grade—even zoo species requiring precise calcium-boron ratios.
Causes of field product failure often include incorrect mixing, moisture exposure, or raw material inconsistency. By reducing manual touchpoints in plant production, automating mixing, and moving toward closed-system filtration, we cut the error rate and produce the same result—batch after batch. Newer granule sizes let oral, capsule, and powder applications integrate faster with feed or water systems, so handlers have fewer problems dosing, especially where automation sets the pace.
We have worked directly with clients who reported “gumming” in their oral drenchers or injectables that “turn cloudy” when used in hot, humid climates. By adjusting hydrate content and batch drying times, and by running pilot-scale trials with those clients, we reduced those problems. These factory-floor corrections turn abstract quality goals into practical animal health improvements. Clients handling large herds, or with non-stop operation schedules, use less API per animal because the response is predictable—they aren’t wasting doses to compensate for underperformance.
By keeping direct feedback loops open—regular check-ins, sample evaluation, and technical troubleshooting hotlines—we help solve immediate client challenges and identify trends that guide future improvement. This partnership focus supports not only our business but the broader veterinary and pharmaceutical communities, who rely on steady, transparently made calcium borogluconate for critical animal care events.
A solid veterinary-calcium API reflects every lesson learned in clinics, barns, tablets presses, and injection lines. From the first days tracking field recoveries to present audits with digital traceability, we produce our Calcium Borogluconate API to perform far beyond the lab—delivering on results that matter most for the animals and the professionals who care for them. Real-world resilience, straightforward feedback channels, and unwavering attention to animal outcomes shape a product trusted worldwide, batch after batch.